Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal


IAEA and PREZODE Pave the Way for Future Cooperation to Prevent Zoonotic Diseases

The International Atomic Energy Agency (IAEA) and the PREZODE (Preventing Zoonotic Disease Emergence) initiative, launched by the President of France Emmanuel Macron earlier this year, agreed today to build further collaborations to prevent the risk of zoonotic diseases emerging.

On the side-lines of the IAEA’s annual gathering of its 173 Member States, representatives of the IAEA’s Zoonotic Disease Integrated Action (ZODIAC) initiative and PREZODE underlined their commitment to work together by signing the PREZODE Declaration of Intent on fighting such diseases that spread from animals to humans.  

Aiming to support countries in detecting and preventing future outbreaks, IAEA Director General Rafael Mariano Grossi launched ZODIAC in June 2020. It builds on the IAEA’s experience in assisting countries in the use of nuclear and nuclear-related techniques for the rapid detection of pathogens that cause animal diseases, including ones that spread to humans.

PREZODE is an international initiative addressing the challenges related to the prevention, surveillance, early detection, and rapid response to risks of zoonotic pandemics. The initiative was announced by President Macron during the One Planet Summit in January this year, in line with the recommendations of a report on biodiversity and pandemics published by the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services in October last year. PREZODE has so far won official support from four countries and more than 30 research organisations, non-governmental organizations, and other initiatives.

IAEA experts will work closely together with PREZODE counterparts to explore areas of collaboration and foster synergies between the two initiatives, for example in capacity building or through the participation of representatives of both initiatives at each other’s events on zoonoses.

“As all of us have experienced over the past year and a half, the current pandemic has shaken the world and continues to plague much of it. For this reason, we must work together and create sustainable partnerships to provide efficient and effective support to countries to prevent future pandemics,” said Director General Grossi. “Our cooperation with PREZODE will create synergies that will benefit the global efforts in this fight.” 

Up to 60% of known human infectious diseases come from animals. These so-called zoonotic diseases affect 2.6 billion people every year, out of which 2.2 million die on average annually.

"PREZODE, a prevention initiative that links scientific research, operational activities, and public decision-making, welcomes the agreement with ZODIAC, in a spirit of cooperation and complementarity that is emblematic of the One Health concept," said Jean-Luc Angot, France’s Special Envoy for the PREZODE initiative.  


The ZODIAC project will establish a global network to help national laboratories in monitoring, surveillance, early detection, and control of animal and zoonotic diseases such as COVID-19, Ebola, avian influenza, and Zika. More than 100 ZODIAC national laboratories are going to benefit from joint research, development activities or expert guidance as well as the technical, scientific, and laboratory support of the IAEA and its partners. It will thus foster scientific collaboration and information sharing.

ZODIAC builds on the experience of the Veterinary Diagnostic Laboratory (VETLAB) Network, a network of veterinary laboratories in Africa and Asia that was originally set up by the Food and Agriculture Organization of the United Nations (FAO) and the IAEA to combat the cattle disease rinderpest. VETLAB now supports countries in the early detection of several zoonotic and animal diseases, such as African swine fever and peste des petits ruminants (PPR).

PREZODE involves more than 1000 actors from universities, schools, national and regional authorities, development agencies, foundations, human, animal, environmental health, and private sector organizations, across the globe.

The initiative is being co-developed by these various actors and will move towards its operational phase in 2022 with an international governance structure. It will consist of:

  • A scientific and operational framework to coordinate research projects, health networks, and operational actions to strengthen an integrated approach and maximize impact.
  • A platform for sharing knowledge acquired through past, current, and future projects and capitalizing on success stories and pilot actions in different regions of the world.
  • A resource center available notably for the One Health High-Level Expert Panel (OHHLEP), to facilitate in particular the development of recommendations for decision makers.

As the cooperation develops, ZODIAC and PREZODE will work towards further operationalizing their collaboration.

The ongoing pandemic shows how state-of-the-art nuclear technologies are part of the response to the related challenges. IAEA set up its ZODIAC initiative right in time, and the cooperation that is being developed between ZODIAC and PREZODE will be an addition to the coordination of international efforts to tackle the risks deriving from zoonotic infectious diseases” said Xavier Sticker, Ambassador and the Permanent Representative of France to the United Nations and International Organisations in Vienna.


The signing of the Declaration on Intent between ZODIAC and PREZODE. Signatories to the are Mr. Pierre Dussort, Operational Manager, PREZODE, and Jean-Pierre Cayol,  Departmental Programme Coordinator, Department of Nuclear Sciences and Applications. 

Witnesses to the event are HE Mr. Xavier Sticker, Resident Representative of France to the IAEA, IAEA Director General Rafael Mariano Grossi, and Najat Mokhtar, IAEA Deputy Director General and Head of the Department of Nuclear Sciences and Applications held at the IAEA 65th General Conference. IAEA, Vienna, Austria. 22 September 2021.

More pictures at: